1. Home
  2. ABCL vs NVRI Comparison

ABCL vs NVRI Comparison

Compare ABCL & NVRI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo AbCellera Biologics Inc.

ABCL

AbCellera Biologics Inc.

HOLD

Current Price

$5.97

Market Cap

1.6B

Sector

Health Care

ML Signal

HOLD

Logo Enviri Corporation

NVRI

Enviri Corporation

HOLD

Current Price

$21.89

Market Cap

1.6B

Sector

Miscellaneous

ML Signal

HOLD

Company Overview

Basic Information
Metric
ABCL
NVRI
Founded
2012
1853
Country
Canada
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Diversified Commercial Services
Sector
Health Care
Miscellaneous
Exchange
Nasdaq
Nasdaq
Market Cap
1.6B
1.6B
IPO Year
2020
2026

Fundamental Metrics

Financial Performance
Metric
ABCL
NVRI
Price
$5.97
$21.89
Analyst Decision
Strong Buy
Analyst Count
5
0
Target Price
$8.40
N/A
AVG Volume (30 Days)
7.5M
424.5K
Earning Date
05-11-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
10.91
N/A
EPS
N/A
N/A
Revenue
$75,128,000.00
N/A
Revenue This Year
N/A
$3.87
Revenue Next Year
$21.85
$3.70
P/E Ratio
N/A
N/A
Revenue Growth
160.56
N/A
52 Week Low
$2.75
$7.70
52 Week High
$8.44
$23.56

Technical Indicators

Market Signals
Indicator
ABCL
NVRI
Relative Strength Index (RSI) 44.40 48.23
Support Level $5.23 $17.79
Resistance Level $6.79 $23.56
Average True Range (ATR) 0.61 1.06
MACD -0.23 -0.17
Stochastic Oscillator 14.66 14.22

Price Performance

Historical Comparison
ABCL
NVRI

About ABCL AbCellera Biologics Inc.

AbCellera Biologics Inc is a clinical-stage biotechnology company focused on discovering and developing first-in-class antibody medicines for indications with high unmet medical need. It has built a platform for advancing antibody drug programs that the company believes provides it with a competitive advantage in addressing challenging, high-value targets such as complex transmembrane proteins and novel modalities, including multispecifics and antibody-drug conjugates. Organisation's pipeline includes two drug candidates in clinical development, two development candidates in Investigational New Drug (IND/Clinical Trial Application (CTA)-enabling activities, and more than 20 active discovery programs across multiple modalities and indications.

About NVRI Enviri Corporation

Enviri Corp is a market-leading, provider of environmental solutions for industrial and specialty waste streams, and equipment and technology for the rail sector. The company's current operations consist of three divisions: Harsco Environmental, Harsco Rail, and Clean Earth. The company gains its revenue from Harsco Environmental segment. Geographically company operates in USA and International Countries, with majority revenue from USA.

Share on Social Networks: